The APTASCRIPT brand, founded in 2014 (Germany), from 640 sister brands and 17478 competing brands. APTASCRIPT is owned by ROCHE HOLDING, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of ROCHE HOLDING is CH0012032048. The sector of APTASCRIPT is Drug Manufacturers.